Table III.
HSP gene expression profile correlation | |||||
---|---|---|---|---|---|
Clinicopathologic characteristics | HSPA1A | HSPA1L | HSPB1 | HSPD1 | TRAP1 |
Histopathology | 0.996 | 0.865 | 0.838 | 0.106 | 0.363 |
Age (years) | 0.797 | 0.309 | 0.723 | 0.287 | 0.451 |
Menarche | 0.782 | 0.713 | 0.68 | 0.554 | 0.351 |
Parity (births) | 0.119 | 0.061 | 0.852 | 0.152 | 0.594 |
Period after Menopause | 0.804 | 0.643 | 0.486 | 0.632 | 0.409 |
CA-125 | 0.222 | 0.806 | 0.539 | 0.842 | 0.315 |
Stage | 0.962 | 0.327 | 0.075 | 0.193 | 0.040 |
Menopause | 0.927 | 0.664 | 0.786 | 0.600 | 0.492 |
Ascites | 0.562 | 0.573 | 0.585 | 0.174 | 0.798 |
Tumor differentiation grade | 0.397 | 0.305 | 0.035 | 0.080 | 0.163 |
Cytoreduction | 0.797 | 0.772 | 0.239 | 0.824 | 0.422 |
Risk of dying | 0.73 | 1.09 | 0.92 | 1.02 | 0.94 |
(P-value) | (0.048) | (0.491) | (0.527) | (0.892) | (0.511) |
TRAP1, TNF receptor associated protein 1; HSP, heat shock protein family; EOC, epithelial ovarian carcinoma.